Cargando…

Subacromial corticosteroid injection versus subcutaneous 5% dextrose in patients with chronic rotator cuff tendinopathy: A short-term randomized clinical trial

AIM: The aim of this study is to compare subcutaneous 5% dextrose versus subacromial corticosteroid injection for the treatment of chronic rotator cuff tendinopathy. METHODS: We carried out a randomized clinical trial with two parallel groups at a university hospital. Overall, 57 (32 women) were inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Amanollahi, Asadollah, Asheghan, Mahsa, Hashemi, Seyed Ebrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Akadémiai Kiadó 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467332/
https://www.ncbi.nlm.nih.gov/pubmed/36343292
http://dx.doi.org/10.1556/1646.11.2019.18
_version_ 1784788169971990528
author Amanollahi, Asadollah
Asheghan, Mahsa
Hashemi, Seyed Ebrahim
author_facet Amanollahi, Asadollah
Asheghan, Mahsa
Hashemi, Seyed Ebrahim
author_sort Amanollahi, Asadollah
collection PubMed
description AIM: The aim of this study is to compare subcutaneous 5% dextrose versus subacromial corticosteroid injection for the treatment of chronic rotator cuff tendinopathy. METHODS: We carried out a randomized clinical trial with two parallel groups at a university hospital. Overall, 57 (32 women) were included in two groups of corticosteroid (n = 29) and dextrose (n = 28). The mean pain score was 6.6 (1.0). We used a visual analog scale for pain and goniometry for the range of motion. The measurements were repeated 1 month after the interventions. For corticosteroid, a single injection of triamcinolone and 1% lidocaine, and for dextrose, a mixture of 5% dextrose and 2% lidocaine three times weekly were prescribed. RESULTS: Both interventions were effective in decreasing pain compared to the baseline (both p < 0.001). The difference in pain between the two groups was nearly significant 1-month post-intervention (p = 0.052). The comparison of the two groups in considerable pain reduction (≥2.8) was in favor of dextrose (p = 0.046). The differences in the range of motion were not conclusive. None of the participants reported an important adverse effect. CONCLUSION: The 5% dextrose treatment is at least as effective as corticosteroid for reducing pain in patients with rotator cuff tendinopathy.
format Online
Article
Text
id pubmed-9467332
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Akadémiai Kiadó
record_format MEDLINE/PubMed
spelling pubmed-94673322022-09-23 Subacromial corticosteroid injection versus subcutaneous 5% dextrose in patients with chronic rotator cuff tendinopathy: A short-term randomized clinical trial Amanollahi, Asadollah Asheghan, Mahsa Hashemi, Seyed Ebrahim Interv Med Appl Sci Original Paper AIM: The aim of this study is to compare subcutaneous 5% dextrose versus subacromial corticosteroid injection for the treatment of chronic rotator cuff tendinopathy. METHODS: We carried out a randomized clinical trial with two parallel groups at a university hospital. Overall, 57 (32 women) were included in two groups of corticosteroid (n = 29) and dextrose (n = 28). The mean pain score was 6.6 (1.0). We used a visual analog scale for pain and goniometry for the range of motion. The measurements were repeated 1 month after the interventions. For corticosteroid, a single injection of triamcinolone and 1% lidocaine, and for dextrose, a mixture of 5% dextrose and 2% lidocaine three times weekly were prescribed. RESULTS: Both interventions were effective in decreasing pain compared to the baseline (both p < 0.001). The difference in pain between the two groups was nearly significant 1-month post-intervention (p = 0.052). The comparison of the two groups in considerable pain reduction (≥2.8) was in favor of dextrose (p = 0.046). The differences in the range of motion were not conclusive. None of the participants reported an important adverse effect. CONCLUSION: The 5% dextrose treatment is at least as effective as corticosteroid for reducing pain in patients with rotator cuff tendinopathy. Akadémiai Kiadó 2019-11-11 2020-09 /pmc/articles/PMC9467332/ /pubmed/36343292 http://dx.doi.org/10.1556/1646.11.2019.18 Text en © 2019 The Author(s) https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium for non-commercial purposes, provided the original author and source are credited, a link to the CC License is provided, and changes – if any – are indicated.
spellingShingle Original Paper
Amanollahi, Asadollah
Asheghan, Mahsa
Hashemi, Seyed Ebrahim
Subacromial corticosteroid injection versus subcutaneous 5% dextrose in patients with chronic rotator cuff tendinopathy: A short-term randomized clinical trial
title Subacromial corticosteroid injection versus subcutaneous 5% dextrose in patients with chronic rotator cuff tendinopathy: A short-term randomized clinical trial
title_full Subacromial corticosteroid injection versus subcutaneous 5% dextrose in patients with chronic rotator cuff tendinopathy: A short-term randomized clinical trial
title_fullStr Subacromial corticosteroid injection versus subcutaneous 5% dextrose in patients with chronic rotator cuff tendinopathy: A short-term randomized clinical trial
title_full_unstemmed Subacromial corticosteroid injection versus subcutaneous 5% dextrose in patients with chronic rotator cuff tendinopathy: A short-term randomized clinical trial
title_short Subacromial corticosteroid injection versus subcutaneous 5% dextrose in patients with chronic rotator cuff tendinopathy: A short-term randomized clinical trial
title_sort subacromial corticosteroid injection versus subcutaneous 5% dextrose in patients with chronic rotator cuff tendinopathy: a short-term randomized clinical trial
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467332/
https://www.ncbi.nlm.nih.gov/pubmed/36343292
http://dx.doi.org/10.1556/1646.11.2019.18
work_keys_str_mv AT amanollahiasadollah subacromialcorticosteroidinjectionversussubcutaneous5dextroseinpatientswithchronicrotatorcufftendinopathyashorttermrandomizedclinicaltrial
AT asheghanmahsa subacromialcorticosteroidinjectionversussubcutaneous5dextroseinpatientswithchronicrotatorcufftendinopathyashorttermrandomizedclinicaltrial
AT hashemiseyedebrahim subacromialcorticosteroidinjectionversussubcutaneous5dextroseinpatientswithchronicrotatorcufftendinopathyashorttermrandomizedclinicaltrial